Prospective study comparing quality of life between opioids sparing protocol and WHO guideline in metastatic bone cancer
Phase 1
Recruiting
- Conditions
- PainOpioid consumptiomSurvaval rate
- Registration Number
- TCTR20180503005
- Lead Sponsor
- Thai Medical Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
1. Age more than 18
2. Radiographic evidence of bone metastasis with corresponding pain at that site
3. Life expectancy 3 month or more and Kanofsky performance status > 40
4. Moderate to severe bone pain ( pain scose more than 3 out of 10 )
Exclusion Criteria
Patients rufuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare quality of life 1 year Edmonton symptom assessment scale, ESAS, BPI
- Secondary Outcome Measures
Name Time Method Pain score 1 year NRS,Opioid consumption 1 year Morphine equivalent,Opioid related side effect 1 year BPI,Kanofsky score 1 year Kanofsky score